Ezh2 Inhibitors Reverse Resistance to Gefitinib in Primary Egfr Wild-type Lung Cancer Cells
Cited by 1
Related Papers
miR-182 suppresses invadopodia formation and metastasis in non-small cell lung cancer by targeting cortactin gene
|Journal of Experimental & Clinical Cancer Research|2018|92
EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells
|BMC Cancer|2020|68
miR‑21‑5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3
|International Journal of Molecular Medicine|2018|60
Natural Plant Extract Tubeimoside I Promotes Apoptosis-Mediated Cell Death in Cultured Human Hepatoma (HepG2) Cells
|Biological and Pharmaceutical Bulletin|2011|41